共 50 条
- [1] FDG-PET/CT for early prediction of response to neoadjuvant anti-HER2 therapies in HER2-positive breast cancer (BC) patients [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
- [2] Using neoadjuvant therapy response to guide adjuvant therapy in HER2+breast cancer [J]. BREAST, 2019, 44 : S13 - S13
- [3] 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 1551 - 1557
- [5] The Pathological Response of Her2+Breast Cancer with Neoadjuvant Chemotherapy and Radiation Therapy [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E17 - E17
- [6] Value of 18FDG PET for prediction of therapeutic response in HER2+breast cancer: Interim analysis [J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2020, 44 (03): : 181 - 188
- [10] Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer? [J]. EJSO, 2013, 39 (12): : 1358 - 1363